Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06065527 · ClinicalTrials.gov registry record · NA

Future Planning and Well-Being for Individuals With Intellectual Disabilities and Family Caregivers

A NA study of Intellectual Disability, sponsored by Northwell Health.

Recruiting
Registry status
NA
Development phase
1,050
Enrollment target
1
Study location

NCT06065527: Recruiting NA study of Intellectual Disability, sponsored by Northwell Health.

NCT06065527 is a NA study of Intellectual Disability that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 1,050 participants, above the 313-participant average among 26 other Intellectual Disability trials with a reported enrollment target (235% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06065527, a NA study of Intellectual Disability, is actively recruiting participants, sponsored by Northwell Health.

RECRUITING
Registry status
NA
Development phase
1,050 participants
Enrollment target
1
Study location

Study Summary

This study will compare the effectiveness of a web-based long-term care planning tool (Map Our Life) partnered with traditional case management services to traditional case management services partnered with an attention-control Centers for Disease Control and Prevention (CDC) sponsored website on health promotion for people with disabilities. The goal of this clinical trial is to promote long-term care (LTC) knowledge and planning among individuals with intellectual/developmental disabilities (IDD) and their family caregivers to improve social supports, health, and quality of life outcomes.

Primary Outcome

The primary outcome measure is caregiver burden as measured by the Zarit Burden Interview (ZBI). The ZBI is the most commonly used measure of distress among caregivers, and has good clinimetric properties and responsiveness. Responses to each item in the scale are on a 5-point scale ranging from 0 ("Never") to 4("Nearly Always"), with a total score ranging from 0 to 88.

Conditions Studied

Interventions

  • BEHAVIORAL Attention Control
  • BEHAVIORAL Map Our Life

Study Locations (1)

New York

  • Cohen Children's Medical Center - New Hyde Park

Trial Details

FieldValue
Enrollment Target 1,050 participants
Start Date 2023-12-22
Est. Completion 2029-04-30
Phase NA
Northwell Health

370 total trials

What NCT06065527 shows while recruiting

NCT06065527 is an interventional study that assigns participants to a tested intervention. Its 1,050 participants enrollment target places it among the larger protocols in the corpus, above the 313-participant average among 26 other Intellectual Disability trials with a reported enrollment target (235% higher).

The record links to 1 condition, with Intellectual Disability appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.

NCT06065527 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06065527 about?

NCT06065527 is a clinical study titled "Future Planning and Well-Being for Individuals With Intellectual Disabilities and Family Caregivers". This study will compare the effectiveness of a web-based long-term care planning tool (Map Our Life) partnered with traditional case management services to traditional case management services partnered with an attention-control Centers for Disease Control and Prevention (CDC) sponsored website on h...

What is the current status of trial NCT06065527?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,050 participants. The study started on 2023-12-22. Estimated completion is 2029-04-30.

What conditions does trial NCT06065527 study?

This clinical trial studies the following conditions: Intellectual Disability.

What interventions are being tested in trial NCT06065527?

The interventions under investigation include: Attention Control (BEHAVIORAL), Map Our Life (BEHAVIORAL).

Who is sponsoring clinical trial NCT06065527?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06065527 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intellectual Disability

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06065527's enrollment target sits among peer trials

1,050 3rd of 26 higher than 24 of 26 other Intellectual Disability trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Intellectual Disability trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04505618 · 1,050 participants · NA

    Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

  • NCT04511806 · 1,050 participants

    Childhood Cancer Predisposition Study (CCPS)

  • NCT05028972 · 1,050 participants · NA

    Hearing Impairment, Strategies and Outcomes in VA Emergency Departments

  • NCT05915377 · 1,050 participants · NA

    Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06065527, the US trial registry maintained by the National Library of Medicine. NCT06065527 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.